Use of botulinum toxin type A in walking disorders of children with cerebral palsy

Europa Medicophysica

Volumn 37, Issue 2, 2001, Pages 83-92

  Paolicelli, P B ^a   Ferrari, A ^a   Lodesani, M ^a   Muzzini, S ^a   Sassi, S ^a   Maoret, A ^a   Bianchini, E ^a   Cioni, G ^a  

^a DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

Author keywords

Botulinum toxin type A, therapeutic use; Cerebral palsy, therapy; Child; Muscle spasticity; Treatment outcome

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CEREBRAL PALSY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; GASTROCNEMIUS MUSCLE; HAMSTRING; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE CONTRACTILITY; MUSCLE TONE; ORTHOSIS; PATHOPHYSIOLOGY; PHYSIOTHERAPY; SOLEUS MUSCLE; SPASTICITY; STANDING; TIBIALIS POSTERIOR MUSCLE; TREATMENT OUTCOME; TREATMENT PLANNING; WALKING;

EID: 0034778525     PISSN: 00142573     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Botulinum toxin: Mechanism of presynaptic blockade
2. Therapeutic uses of botulinum toxin
3. Treatment of spacsticity with botulinum toxin: A double blind study
4. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients
5. Tossina botulinica e riabilitazione: Una nuova sinergia?
6. Management of cerebral palsy with botulinum-A toxin: Preliminary investigation
7. Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double blind trial
8. Botulinum toxin in the management of the lower limb in cerebral palsy
9. Botulinum toxin A in management of cerebral palsy
10. Injections of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: A 3-dimensional motion analisys study
11. Use of botulinum toxin jniection in 17 children with spastic cerebral palsy
12. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: A randomized prospective trial
13. Double-blind study of botulinum A toxin jniections into the gastrocnemius muscle in patients with cerebral palsy
14. Botulinum chemodenervation: A new modality in cerebral palsied hands
15. Botulinum toxin A in the hemiplegic upper limb: Double-blind trial
16. Botulinum toxin treatment in cerebral palsy: Intervention with poor evaluation?
17. Paralisi cerebrali infantili: Appunti di viaggio intorno al problema della classificazione
18. Anticipatory dynamical system, intrinsic patterns and skill learning
19. Spasticity and spastic gait in children with cerebral palsy
20. Schede illustrative delle forme più frequenti di paralisi cerebrale infantile (forme spastiche)
21. MRI and clinical characteristics of children with hemiplegic cerebral palsy
22. Interater-reliability of a modified Ashworth scale of musle, spasticity
23. Protocollo di video-registrazione
24. The gross motor function measure: A means to evaluate the effects of physical therapy
25. Goal attainment scaling: A general method for evaluating community mental health programs
26. Goal attainment scaling as a major of change in infants with motor delay
27. Botulinum toxin in the treatment of cerebral palsy
28. Botulinum toxin type A (BTA) in the treatment of lower-limb spasticity associated with cerebral palsy
29. The use of botulinum toxin type A in children with cerebral palsy: A retrospective study
30. Relation of gait analysis to gross motor function in cerebral palsy
31. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy
32. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy